In order to predict the possible evolution of ALK+ ALCL under ALKi pressure, and to study cross-resistance among the available drugs, we recently set up an in vitro model of acquired resistance to selective ALK inhibition in ALCL [12, 13]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.